Pharmacy Residency Programs
PGY-2 Investigational Drugs and Research Pharmacy Residency
Contact Information:
jemurphy@health.ucdavis.edu
UC Davis Health
Pharmacy Department
2315 Stockton Blvd
Sacramento, CA 95817
Residency Program Director
Jennifer Murphy, PharmD, BCOP
Senior Pharmacist, Oncology & Investigational Drug Service
PGY2 Investigational Drugs and Research Pharmacy Residency Program Director
Volunteer Assistant Clinical Professor, UCSF School of Pharmacy
Investigational Drug Service, Cancer Center (IDSCC)
Department of Pharmacy Services, UC Davis Health
2024-2025 Resident:
Kiet Nguyen, PharmD
ASHP Residency Directory listing
University of California Davis Medical Center PGY2 Investigational Drugs and Research Pharmacy Residency Purpose
PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.
Program Overview
The Investigational Drugs and Research Pharmacy Residency at the University of California, Davis Medical Center, is a one-year, PGY2 specialty residency in Investigational Drug Services and Research Pharmacy Residency. The residency is supported by the Department of Pharmacy.
The Investigational Drug Services (IDS) is a strong, well-established, and progressive center of excellence at the UC Davis Medical Center. The IDS manages investigational products for a robust portfolio of Phase I, II, and III studies which are conducted through the UC Davis Medical Center hospital, hospital-based clinics, Alpha Stem Cell Clinic, and UC Davis Comprehensive Cancer Center. UC Davis Medical Center is a Level 1 Trauma Center located on the main Sacramento health campus which also houses the CIRM awarded UC Davis Alpha Stem Cell Clinic, the Mind Institute, and the UC Davis Comprehensive Cancer Center. The UC Davis Cancer Center is an NCI-designated Comprehensive Cancer Center as well as a member of the National Comprehensive Cancer Network (NCCN). UC Davis Medical Center is home to the Sacramento Citywide Oncology Phase I Program (SCOPE) and is within the top awarded institutions for NIH funding, with individual researchers within the top percentage of recipients. At UC Davis Medical Center, Investigational Products are dispensed from various pharmacy locations including the main hospital IDS pharmacy, IDS Cancer Center Pharmacy, central IV pharmacy, Inpatient Oncology Pharmacy, outpatient pharmacies, and the UC Davis Cancer Center Infusion Pharmacy. The Investigational Drugs and Research Pharmacy Residency will provide each resident with a comprehensive training and educational experience in clinical trial pharmacy practices.
UC Davis Medical Center and Pharmacy Services
UC Davis Medical Center is a major academic health center located in Sacramento, California. The Department of Pharmacy Services recruits, hires, and trains caregivers to provide progressive pharmacy services as collaborative team members to support optimal patient outcomes.
More about the Department of Pharmacy Services can be found on our Webpage
Program Design
The UC Davis Medical Center PGY2 Investigational Drugs and Research Pharmacy Residency is designed to meet the educational goals and objectives as outlined by the ASHP Accreditation Standard for Postgraduate Pharmacy Residency Programs.
Educational Outcomes Required by the Accreditation Standard:
R1. Patient Care
R2. Advancing Practice and Improving Patient Care
R3. Research Protocols and Regulations
R4. Leadership and Management
R5. Teaching, Education, and Dissemination of Knowledge
Electives may be added based on available resources and resident interest.
Program Structure
UC Davis Medical Center PGY2 Investigational Drugs and Research Pharmacy Residency Learning Experiences:
The residency learning experiences will primarily be divided into block rotations and longitudinal learning experiences. Most block rotations will be one month in duration. Some rotations may be in 2-4 week increments. Rotation schedules will be determined based on availability and resident interests. Rotation schedules may be adjusted and updated with the resident at each quarterly development plan.
Visit the Program Overview for additional details about program structure, program overview, committee assignments, professional development, staffing requirements, learning experience descriptions, and other aspects of the residency program.
Required Block Rotation Experiences
|
Rotation |
Duration |
Overview |
| Orientation and IDS Training | Block (1 month) |
Orientation to UC Davis Medical Center, pharmacy residency program policies and the specific residency program. Training for IDS Pharmacy Coverage and Department of Pharmacy Service (DPS) Evening Support will occur during this time. Duration may be adjusted based on the resident’s previous experience and knowledge of UC Davis Medical Center. |
| IDS Practice Foundations | Block (1 month) |
This rotation provides the resident with a strong overview of the IDS pharmacy practice, including hands on learning for conducting trial feasibility, inventory management, dispensing workflows, set-up and maintenance throughout the trial lifecycle. |
| Investigational Drug Service I (IDS I) | Block (1 month) |
Provides introduction to processes related to dispensing and managing investigational drugs, ERX development, and clinical trials in the non-oncology IDS Pharmacy. |
| Investigational Drug Service Cancer Center I (IDSCC I) | Block (1 month) |
Provides introduction to processes related to dispensing and managing investigational drugs, ERX development, and clinical trials in the IDS Cancer Center Pharmacy. The resident will also attend at least one half-day of a medical oncology clinic (e.g. lung cancer clinic) with a PI to provide an overview of the ambulatory workflow in oncology and clinical trial patient care and observe the relationship to IDSCC operations. |
| Protocol Management I | Block (1 month) |
This rotation immerses the resident in the day-to-day management of the internal medicine and surgery clinical trials portfolio. Areas of focus will include study start-up tasks such as feasibility assessments, fee schedule development, order set development, and ERX creation as well as participation in the maintenance of trials at various points in their lifecycle. Topic discussions will include the budgeting process, Medicare coverage analysis, budgets, contracts, and finance. |
| Protocol Management II | Block (1 month) |
This learning experience builds upon Protocol Management I to provide the resident with experience in the start-up of oncology clinical trials and an introduction to oncology trial maintenance. |
| Cancer Center Outpatient Infusion | Block (1 month) |
Cancer Center Outpatient Infusion will focus on the fundamentals of the Infusion Pharmacy workflow, with an emphasis on oversight of preparation and dispensing of chemotherapy and investigational drugs. The resident will be introduced to the process of reviewing and processing of chemotherapy orders; management and prevention of chemotherapy-related toxicities; medication safety/preventing chemotherapy errors; patient counseling. |
| Ambulatory Care Clinic (non-Oncology) | Block (1 month) |
Ambulatory clinic rotation in a setting with robust pharmacy services and clinical trial study teams. Clinic experiences will be assigned based on the current clinical trial portfolio and ambulatory care service pharmacists to provide exposure to patient populations, clinic workflow, clinical pharmacist services, recruitment, retention, and treatment workflows, study team member roles, and clinical trials treatment. Clinic options may include, but are not limited to: Infectious Disease, Pulmonary Critical Care, Physical Medicine & Rehab, Neurology, or Transplant. |
| Protocol Management III | Block (1 month) |
This learning experience builds upon Protocol Management I and II to provide the resident with a robust, focused experience on managing oncology clinical trials during their active life cycle as well as additional experience setting-up studies and IDS budgets. |
| Scholarship and Precepting | Block (1 month) |
This rotation provides the resident with the opportunity to engage in precepting with other learners (students or residents) and to develop their precepting skills. To run concurrently with another learning experience. |
| Investigational Drug Service II (IDS II) or IDS Cancer Center II (IDSCC II) | Block (1 month) |
The rotation will focus on the coordination and synthesis of activities in the IDS Pharmacy. The emphasis will be focused on review, implementation, modification, and feasibility of clinical trials and pharmacy workflow management while overseeing overall IDS pharmacy operations. This rotation is the capstone of the residency integrating all information learned throughout the year, allowing the resident to showcase their independence and practice autonomously as an IDS pharmacist. |
Required Longitudinal Rotation Experiences
- Research/ QI Project
- Grand Rounds
- IDS Pharmacy Practice Management
- Protocol Development
- IDS BEACON
- IRB/Regulatory Affairs
- DPS Coverage: Ambulatory Infusion Pharmacy Services
- DPS Evening/Block Staffing
Elective Experiences
- Alpha Stem Cell Clinic (ASCC)
- Advanced ASCC
- Cellular Therapy Service
- Pediatric Oncology
- Inpatient Medical Oncology
- Protocol Development
- Drug Development
- Oncology Specialty Pharmacy
- Research Quality and Safety
- IDS Pharmacy Practice Management
Elective length may vary if multiple learning experiences are scheduled to fulfill a one-month period (e,g, two electives or one week of required rotation plus an elective). Additional elective rotations can be developed based on the clinical trial portfolio available at the time, and the interests of the resident. Any such modification will be noted in the customized development plan.
Additional Opportunities
Based on interest, the clinical trial portfolio, and current therapeutic and trial management advancements, the resident may choose to attend Clinical and Translational Science Center (CTSC) education courses when applicable to shadow at the Clinical Research Center (CCRC) and the Office of Clinical Research (OCR). Other opportunities identified can be attended with approval from the RPD. These are optional experiences that may be incorporated into the residency year based on resident interest to increase their foundational knowledge and augment their self-driven, independent, professional development.
Example Resident Schedule (subject to change):
|
Quarter 1 |
Quarter 2 |
Quarter 3 |
Quarter 4 |
|
July
|
October
|
January
|
April
|
|
August
|
November
|
February
|
May
|
|
September
|
December
|
March
|
June
|
Assignment of Education Goals and Objectives to Specific Learning Experiences
The UC Davis Medical Center PGY2 Investigational Drugs and Research Pharmacy Residency is designed to provide the resident with a broad range of experiences in a variety of practice settings. Required learning experiences have been designed to meet the content requirements, as outlined in the ASHP PGY2 Investigational Drugs and Research Pharmacy Residency required competency areas, goals and objectives and to provide exposure to the key investigational drugs and research pharmacy residency topic references.
Criteria for Successful Completion of the PGY2 Investigational Drugs & Research Pharmacy Residency
Requirements and expectations for graduation are located at: Requirements for Successful Graduation
Resident Personnel Policies:
The Pharmacy Resident Personnel Manual is located at Pharmacy Resident Personnel Manual
Topics in the manual include, but are not limited to:
- Resident Qualifications
- Early Commitment Policy
- Pre-employment drug testing
- Health insurance and Benefits
- California pharmacist licensure requirement
- Moonlighting
- Duty hours/tracking of duty hours
- Professional, family, and extended leave policies
- Dismissal policy and consequences of failure to progress
